Answer
Yes, postmarketing cases of bullous pemphigoid requiring hospitalisation have been reported with DPP4 inhibitors, including saxagliptin hydrochloride.
Sources for this answer
- Onglyza 5mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 26Document updated
Sources checked